Mom & Baby well-being → healthy population futures. The vision of the company is to make this a reality.
We are developing the first digital therapeutic for postpartum depression. The goal is to improve care outcomes and effectiveness of treatment for postpartum mothers and opioid addicted mothers suffering from anxiety/depression as a dual comorbidity, a key cause of overdose. Join us and support our vision.